InvestorsHub Logo
Followers 18
Posts 532
Boards Moderated 0
Alias Born 05/11/2011

Re: faithabides post# 191846

Thursday, 06/11/2020 7:13:02 AM

Thursday, June 11, 2020 7:13:02 AM

Post# of 278616

Just so you are aware .. this stock did a 9 for 1 split a little over 10 years to generate more interest. The natural thing would be to basically back that out to uplist with a 1 for 10.



Those are very good points.

I don't think a lot of people know/remember the story of how all that stuff went down.  For those who want a brief history, it went like this:

Back in the beginning of 2009 we were at the hight of the financial meltdown.  At that time, Kraig Labs was a tiny biotech company that had yet to have any scientific breakthrough success.  There was absolutely no investment appetite in these types of companies during this time.  Many small biotechs ended up shutting down and closing their doors permanently.  Kim decided he didn't want to give up because, after all, most of the seed investment for KBLB at the time had come from friends and family.  He also felt he was close to his first breakthrough.

Even exchanges like the OTC have listing requirements.  One in particular is a volume minimum requirement.  In the beginning of 2009, there were many days that KBLB didn't even trade a single share.  This put the company at risk of being delisted from the OTC which would essentially dissolve the company.  But, after some advice, Kim ended up making a tactical and savvy move.  His stock was trading at $.30, so he decided to do a forward split of 1-10 on May 28th, 2009 and make his stock worth $.03 at the time.  Why would a CEO purposely decrease shareholders share price but increase their share count?  Well the OTC didn't have price requirements, only volume requirements.  This move multiplied KBLB's volume by 10 and kept the company afloat long enough for him to finally achieve his fist breakthrough at Notre Dame in late 2010.

Kim knew that he likely would need to reconcile this decision sometime later, but at the time, it was the only way to save the company. 

It is now time for Kraig Labs to revert back to something much closer to it's initial share structure.  If Kim didn't need to do that early forward split, we likely would have been at a high enough share price last year to uplist organically, but then again, the company wouldn't even exist without the forward split.  So this is where we're at and I commend Kim for coming this far with this company, even with the many missteps along the way.  But because he made some of those tough early decisions, all of us have an opportunity to share in this company's present and future success.  
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KBLB News